Eagle Pharmaceuticals, Inc. Ownership
$1.29
0.00%
Nasdaq, Sep 16, 09:30 am EDT.
Eagle Pharmaceuticals, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Nantahala Capital Management, LLC
|
4.945m | — | — | Jun 30 2025 |
| 2 |
J. Goldman & Co., L.P.
|
667.108k | — | +667.108k | Jun 30 2025 |
| 3 |
Ajovista LLC
|
56.438k | — | +45.206k | Sep 30 2024 |
| 4 |
Stanley-Laman Group, Ltd.
|
12.000k | — | — | Mar 31 2026 |
| 5 |
BlackRock Fund Advisors
|
2.310k | — | — | Nov 30 2025 |
|
1
Nantahala Capital Management, LLC
|
4.945m
|
|
2
J. Goldman & Co., L.P.
|
667.108k
|
|
3
Ajovista LLC
|
56.438k
|
|
4
Stanley-Laman Group, Ltd.
|
12.000k
|
|
5
BlackRock Fund Advisors
|
2.310k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. |
Recent Eagle Pharmaceuticals, Inc. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Sep 18 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Sep 15 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Sep 11 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 06 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Aug 31 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Aug 24 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Sep 18 2026
$182.45
|
|
Sarah Chen
SALES
|
Sep 15 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Sep 11 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 06 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Aug 31 2026
$170.50
|
|
Lisa Park
SALES
|
Aug 24 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
